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ABSTRACT Group A Streptococcus (GAS, Streptococcus pyogenes) is an ongoing threat to human health as the agent of streptococ-
calpharyngitis,skinandsofttissueinfections,andlife-threateningconditionssuchasnecrotizingfasciitisandstreptococcal
toxicshocksyndrome.Inanimalmodelsofinfection,macrophageshavebeenshowntocontributetohostdefenseagainstGAS
infection. However, as GAS can resist killing by macrophages in vitro and induce macrophage cell death, it has been suggested
thatGASintracellularsurvivalinmacrophagesmayenablepersistentinfection.Usingisogenicmutants,wenowshowthatthe
GASpore-formingtoxinstreptolysinO(SLO)anditscotoxinNAD-glycohydrolase(NADase)mediateGASintracellularsurvival
andcytotoxicityformacrophages.Unexpectedly,thetwotoxinsdidnotinhibitfusionofGAS-containingphagosomeswithlyso-
somesbutratherpreventedphagolysosomeacidiﬁcation.SLOservedtwoessentialfunctions,porationofthephagolysosomal
membraneandtranslocationofNADaseintothemacrophagecytosol,bothofwhichwerenecessaryformaximalGASintracellu-
larsurvival.WhereasNADasedeliverytoepithelialcellsismediatedbySLOsecretedfromGASboundtothecellsurface,inmac-
rophages,thesourceofSLOandNADaseisGAScontainedwithinphagolysosomes.WefoundthattransferofNADasefromthe
phagolysosometothemacrophagecytosoloccursnotbysimplediffusionthroughSLOporesbutratherbyaspeciﬁctransloca-
tionmechanismthatrequirestheN-terminaltranslocationdomainofNADase.Theseresultsilluminatethemechanisms
throughwhichSLOandNADaseenableGAStodefeatmacrophage-mediatedkillingandprovidenewinsightintothevirulence
ofamajorhumanpathogen.
IMPORTANCE Macrophagesconstituteanimportantelementoftheinnateimmuneresponsetomucosalpathogens.Theyingest
andkillmicrobesbyphagocytosisandsecreteinﬂammatorycytokinestorecruitandactivateothereffectorcells.GroupA Strep-
tococcus (GAS, Streptococcus pyogenes), an important cause of pharyngitis and invasive infections, has been shown to resist kill-
ingbymacrophages.WeﬁndthatGASresistancetomacrophagekillingdependsontheGASpore-formingtoxinstreptolysinO
(SLO)anditscotoxinNAD-glycohydrolase(NADase).GASbacteriaareinternalizedbymacrophagephagocytosisbutresistkill-
ingbysecretingSLO,whichdamagesthephagolysosomemembrane,preventsphagolysosomeacidiﬁcation,andtranslocates
NADasefromthephagolysosomeintothemacrophagecytosol.NADaseaugmentsSLO-mediatedcytotoxicitybydepletingcellu-
larenergystores.TheseﬁndingsmayexplainthenearlyuniversalproductionofSLObyGASclinicalisolatesandtheassociation
ofNADasewiththeglobalspreadofaGAScloneimplicatedininvasiveinfections.
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G
roup A Streptococcus (GAS, Streptococcus pyogenes)i sa
human-restricted pathogen that is responsible for a wide va-
riety of diseases, ranging from superﬁcial infections of the throat
(pharyngitis) and skin (impetigo) to invasive and life-threatening
conditions such as necrotizing fasciitis and streptococcal toxic
shock syndrome, as well as the postinfectious sequelae of acute
rheumatic fever and glomerulonephritis (1). Although GAS is
generally considered an extracellular pathogen, intracellular res-
ervoirs of viable GAS have been reported in epithelial cells (2–4),
neutrophils (5), and macrophages (6). It has been suggested that
survival of GAS within host cells may promote the persistence of
the organisms during colonization or infection by shielding them
from immune effectors and antibiotics.
Macrophages represent one of the earliest immune cells en-
countered by bacteria during infection. As a front line of the in-
nate immune response, macrophages phagocytose bacteria and
produce inﬂammatory mediators to recruit and activate other ef-
fector cells, including neutrophils. Depletion of macrophages in
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rate after an intravenous challenge with GAS, a result that implies
thatmacrophagescontributetoclearanceofGASfromtheblood-
stream (7). In a mouse model of invasive soft tissue infection,
clodronatetreatmenttodepletemacrophageswasassociatedwith
no change in the viable bacterial count at the site of subcutaneous
inoculation but increased dissemination, as evidenced by quanti-
tative cultures of blood and spleen (8). These studies support a
critical role for macrophages in the control of GAS infection.
However, other studies suggest that GAS virulence determi-
nants may target macrophages and reduce their effectiveness in
bacterial clearance. A study of clinical specimens from patients
with invasive soft tissue infections suggested that GAS can over-
come macrophage-mediated bactericidal mechanisms and sur-
vive within macrophages for prolonged periods at sites of severe
invasiveinfection(6).AnotherstudyfoundthatMtype1GASbut
not an M protein-negative mutant, survived for at least several
hours in macrophages and that viable GAS bacteria were released
from infected cells (9). These results imply not only that virulent
strains of GAS may resist killing by macrophages but also that
macrophages could provide a sanctuary site for intracellular sur-
vival and a vehicle for dissemination of infection to the blood, to
deep tissues, or to visceral organs.
GAS bacteria secrete several extracellular factors that are
thought to contribute to pathogenesis (1, 10). Among these is
streptolysin O (SLO), a member of the large family of pore-
forming toxins known as cholesterol-dependent cytolysins
(CDCs). CDCs share the property of binding to cholesterol-
containing membranes, where they oligomerize and insert them-
selves to form large pores (11–13). CDCs are produced by many
Gram-positive bacteria, and some of them have been character-
izedasimportantvirulencefactors(14,15).Studiesfromourlab-
oratory have shown that SLO interferes with phagocytosis of GAS
bymacrophagesandcontributestobothcytotoxicinjuryandGAS
intracellular survival (16). Others have shown that SLO induces
oncosis or apoptosis of macrophages (17, 18).
SLO is intimately associated with another toxin, NAD-
glycohydrolase (NADase), a secreted enzyme that catalyzes the
hydrolysis of NAD to nicotinamide and adenosine diphospho-
ribose(19).Theslogeneformspartofanoperontogetherwithnga
and ifs, which encode NADase and its intracellular inhibitor IFS,
respectively(20,21).SLOisalsofunctionallylinkedtoNADasein
that NADase translocation into epithelial cells after its secretion
byextracellularGASisdependentonSLO(22,23).Afterinternal-
ization of GAS by keratinocytes, SLO damages the bacterium-
containing vacuole and triggers targeted autophagy, a process
through which the bacteria are surrounded by an
autophagosome-likecompartment(24,25).SLOandNADasein-
hibit the fusion of this compartment with lysosomes, thereby en-
hancing GAS survival in keratinocytes (22, 23, 25, 26).
In view of the interdependence of SLO and NADase in the cell
biology of GAS infection of epithelial cells, it seems likely that
NADase also plays a key role in modulating cytotoxicity and in-
tracellular survival in macrophages. Whether macrophages suc-
cessfully control GAS infection or rather are exploited by GAS for
intracellular survival, persistence, and dissemination likely de-
pends on the effects of virulence factors such as SLO and NADase
that regulate bacterial uptake, intracellular survival, cytolytic ef-
fects on the macrophage, and the eventual emergence of viable
GAS in host tissues.
We investigated the roles of SLO and NADase in the interac-
tion of GAS with human macrophages with the goal of under-
standing how GAS resists phagocytic killing during infection.
UsingavirulentstrainrepresentativeoftheM1T1clonalgroup
widely implicated in invasive GAS disease, we found that both
toxins play a critical role in GAS intracellular survival in infected
macrophages by two mechanisms. SLO pore formation prevents
acidiﬁcation of the GAS-containing phagolysosome, thereby im-
pairing effective bacterial killing. In addition, SLO-mediated
translocationdeliversNADasefromthephagosomeintothemac-
rophage cytosol, where NADase augments the cytotoxic effects of
SLO, presumably by inhibiting cellular repair mechanisms. Thus,
synergistic effects of the two toxins mediate cytotoxic injury to
infected macrophages and enhance GAS intracellular survival.
RESULTS
SLO and NADase promote GAS resistance to killing by macro-
phages. To further characterize the roles of SLO and NADase in
GAS interactions with macrophages, we compared the intracellu-
lar survival of wild-type strain 854 with that of several isogenic
mutants.Strain854isaclinicalisolatefromapatientwithinvasive
GAS infection and is representative of the globally disseminated
M1T1 clone implicated in many such infections since the 1980s
(27–29). We found that mutants deﬁcient in SLO (the slo mu-
tant)orNADase(thengamutant)wereimpairedinintracellular
survival in macrophages compared to the parent strain (Fig. 1A
and B). To determine whether NADase enzymatic activity is re-
quired for optimal survival, we constructed an nga(G330D) mu-
tant in which substitution of aspartic acid for glycine at position
330 reduces enzymatic activity by 5,000-fold, effectively abrogat-
ingNADaseactivity(25,30).Themutanthadsurvivalrateslower
than those of the wild-type strain and slightly higher than but not
signiﬁcantly different from those of the nga mutant in macro-
phages(Fig.1C).ThisresultconﬁrmstherequirementofNADase
activityforoptimalGASsurvivalinmacrophages.Takentogether,
these data indicate that both SLO and NADase are required for
optimal GAS resistance to killing by macrophages.
Inseparateexperiments,tofurtherassesstheeffectofSLOand
NADase expression on GAS interactions with macrophages, we
quantiﬁed the lactate dehydrogenase (LDH) released by macro-
phagesinfectedwith854oritsmutantsasamarkerofcytotoxicity.
As shown in Fig. 2, LDH release by macrophages exposed to the
wild-type strain increased over the course of infection, whereas
cells exposed to the slo or nga mutant showed minimal cyto-
toxicity. The nga(G330D) mutant, which expresses enzymatically
inactive NADase, also induced minimal cytotoxicity at time zero
andat2h,withaslightincreaseat4hthatmaybeexplainedbythe
low level of residual NADase activity of the mutant enzyme (30).
ThesedataindicatethatbothSLOandNADasecontributetoGAS
cytotoxicity for macrophages.
SLOporeformationpromotescytotoxicityandGASsurvival
inmacrophages.TheexperimentsdescribedaboveimplicateNA-
Dase as playing a central role in both the cytotoxic effects of GAS
on macrophages and in GAS intracellular survival. Because NA-
Dase delivery into the host cell cytosol depends on SLO, we con-
sidered whether the role of SLO in cytotoxicity and intracellular
survivalmightbesimplytotranslocateNADase,ratherthandirect
cellularinjuryduetoSLOporeformation.Toassessthecontribu-
tion of SLO pore formation to cytotoxicity and intracellular sur-
vival, we constructed a SLO mutant that harbors a single amino
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(31). SLO(Y255A) retains the abilities to insert itself into
cholesterol-containing membranes and to translocate NADase as
efﬁciently as wild-type SLO, but it lacks pore-forming or hemo-
lytic activity (25, 31). The slo(Y255A) mutant was less cytotoxic
for macrophages than parent strain 854 but more cytotoxic than
the slo mutant (Fig. 2). Similarly, results in Fig. 1D show an
intermediatelevelofsurvivaloftheslo(Y255A)mutantcompared
to that of wild-type strain 854. These results indicate that both
SLOporeformationanditsroleindeliveryofNADasecontribute
to GAS intracellular survival and cytotoxicity in macrophages.
We inferred that the higher levels of cytotoxicity and intracel-
lularsurvivalobservedinmacrophagesexposedtotheslo(Y255A)
mutantthaninthoseexposedtotheslomutantwereattributable
to the intracellular enzymatic activity of NADase, which is deliv-
ered to cells infected with the slo(Y255A) mutant but not to those
infected with the slo mutant. To test this hypothesis directly, we
constructed a slo(Y255A) nga(G330D) double mutant that does
not form SLO pores and expresses an inactive NADase. As ex-
pected,macrophagesexposedtothedoublemutantwereindistin-
guishable from those exposed to the slo mutant with respect to
defective intracellular survival and the complete absence of cyto-
toxicity (Fig. 1E and 2, respectively). Taken together, the data
indicate that both SLO pore formation and NADase activity are
required for GAS to evade killing by macrophages.
SLOandNADasedonotinhibitlysosomalfusionwithGAS-
containingphagosomes.TobetterunderstandhowGASsurvives
in macrophages, we investigated the mechanism by which SLO
and NADase promote GAS resistance to phagocytic killing. After
phagocytic uptake of a microbe, effective killing depends on the
maturation of the phagosome through a series of membrane fu-
sions with other vacuolar structures to convert the phagosome
into a microbicidal organelle. Pathogens have evolved various
strategies to counteract the host defense and to resist phagocytic
killing. Among these is the arrest or reprogramming of phago-
somal maturation and modiﬁcation of or escape from the phago-
some (32, 33). These mechanisms have been well studied for in-
tracellular pathogens; however, less is known about the fate and
the intracellular localization in macrophages of primarily extra-
cellular pathogens such as GAS. We used confocal microscopy to
investigate the intracellular localization of GAS in macrophages
after phagocytosis. To determine whether the GAS-containing
FIG 1 SLO and NADase are required for maximal survival of GAS in macrophages. Values are the mean numbers of CFU recovered immediately after 90 min
of exposure to GAS (time zero) and 2 and 4 h later, expressed as a percentage of the value at time zero. Data for wild-type GAS strain 854 and the SLO-deﬁcient
slomutantstrainareshowninpanelAandforclarityinpanelsBthroughFincomparisontothoseofindividualmutantstrains.Datarepresentthemeanvalues
 the standard errors from at least four experiments performed in triplicate. *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001.
FIG 2 SLO and NADase mediate GAS cytotoxicity for macrophages. Cell
culture supernatants were collected to measure the LDH released by macro-
phagesat0,2,and4hafterinfection.Cytotoxicityisexpressedasapercentage
of the amount of LDH released by uninfected macrophages lysed with 10%
Triton X-100. Shown are the mean values  the standard errors of four inde-
pendent experiments performed in triplicate. Values for all of the mutant
strainsweresigniﬁcantlydifferentfromthoseforstrain854atthecorrespond-
ing time points. Asterisks indicate other comparisons with statistically signif-
icant differences. **, P  0.01; ***, P  0.001.
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uration, we examined GAS-infected macrophages for colocaliza-
tionofthebacteriawithlysosome-associatedmembraneprotein1
(LAMP-1), an abundant marker of late endosomes and lyso-
somes. As a positive control to assess the speciﬁcity of LAMP-1
stainingandthefunctionalityofthephagosomematurationpath-
way, we used macrophages exposed to heat-killed cells of GAS
strain 854. As anticipated, more than 85% of the heat-killed bac-
teria colocalized with LAMP-1 at 1 h after infection (Fig. 3A and
B).Unexpectedly,internalizedwild-typeandslomutantbacteria
were also associated with the late endosomal/lysosomal marker
LAMP-1 at the same and later time points. This colocalization
suggests that GAS bacteria are quickly trafﬁcked to phagolyso-
somes and that SLO and NADase do not prevent fusion of the
phagosome and LAMP-1-positive lysosomes.
SLO prevents phagolysosomal acidiﬁcation. The greater in-
tracellular survival of wild-type 854 than its isogenic mutants
(Fig. 1) suggested that SLO and/or NADase interfere with
phagolysosomal killing. However, as discussed above, wild-type
GAS bacteria were rapidly trafﬁcked to compartments marked by
LAMP-1, i.e., compartments consistent with mature phagolyso-
somes. This ﬁnding was unanticipated because, in human kera-
tinocytes, GAS production of SLO is associated with impaired
fusion of the GAS-containing vacuole with lysosomes and failure
to acidify this compartment for effective bacterial killing (25, 34,
35). As trafﬁcking to a mature phagolysosome appeared to be
intact in macrophages infected with wild-type GAS, we investi-
gated the possibility that these GAS-containing compartments
were not fully functional. The phagolysosome is biochemically
deﬁned by a markedly acidic pH (4.5 to 5) that is required for
lysosomal hydrolase activation and for cargo degradation (36).
We assessed the ability of bacterium-containing phagolysosomes
to acidify by using the acidotropic probe LysoTracker red DND-
99.Wefoundthatmorethan40%oftheintracellularslomutant
bacteria colocalized with the acidotropic probe after1ho finfec-
tion, whereas only 12% of the wild-type GAS bacteria were asso-
ciated with LysoTracker (Fig. 4). A similar pattern was observed
after2h:80%colocalizationwithLysoTrackerfortheslomutant
comparedto24%forthewild-typestrain.Thesedataindicatethat
the wild-type strain interferes with phagolysosome acidiﬁcation
and implicate SLO in this process.
TofurtherinvestigatetheroleofSLOand/orNADaseininhib-
iting phagolysosomal acidiﬁcation, we examined the association
of the nga(G330D) mutant with LysoTracker in infected macro-
phages. This mutant behaved similarly to the wild-type parent
strain with respect to its failure to colocalize with LysoTracker, a
result that suggests that SLO production, even in the absence of
enzymatically active NADase, is sufﬁcient to impair phagolyso-
somalacidiﬁcation(Fig.4).TotestwhetherSLOporeformationis
required to inhibit acidiﬁcation, we examined cells infected with
the non-pore-forming slo(Y255A) mutant. The slo(Y255A) mu-
tant strain also was located predominantly in nonacidic compart-
ments, similar to wild-type GAS (Fig. 4). Two hypotheses could
explain this result. (i) Because SLO(Y255A) does not form pores
but does insert itself into cell membranes as a prepore complex
(31), it is possible that the prepore complexes might perturb
membrane integrity sufﬁciently to disrupt the proton gradient
responsible for acidiﬁcation of the phagolysosome. (ii) Alterna-
tively, NADase produced by the slo(Y255A) mutant could be re-
sponsible for inhibiting phagolysosome acidiﬁcation by depleting
NAD and, secondarily, ATP, which is required to power the
vacuolar proton-ATPase pumps that establish the proton gradi-
ent. To distinguish between these hypotheses, we examined cells
infected with the nga(G330D) slo(Y255A) double mutant, which
expressesnon-pore-formingSLOandenzymaticallyinactiveNA-
Dase (Fig. 4). We found that this mutant was also located in non-
acidic vacuoles, suggesting that NADase is not required for inhi-
bition of acidiﬁcation and that insertion of SLO(Y255A) is
sufﬁcient to disrupt the phagolysosomal proton gradient.
SLO pore formation damages the phagolysosomal mem-
brane. In light of our ﬁndings that SLO is required to inhibit
phagolysosome acidiﬁcation, it is likely that SLO secreted by
FIG 3 SLO and NADase do not prevent lysosome fusion to the GAS-containing phagosome. (A) Confocal microscopy images showing colocalization of
LAMP-1(Alexa568,red)andheat-killedGASstrain854(HK),live854,ortheslomutant(Alexa488,green).Extracellularbacteriawerestainedbothgreenand
blue (Alexa 660). Representative images from one experiment are shown. Scale bars  10 m. The percentage of intracellular bacteria of each strain colocalized
with LAMP-1 is indicated. (B) Percentage of intracellular GAS associated with LAMP-1 after 1 h (white bars) or 2 h (gray bars) of infection. Mean values  the
standard errors of at least three independent experiments are shown.
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and disrupts the proton gradient by permitting diffusion of sol-
utes across the damaged membrane. To further assess membrane
damage in GAS-containing phagolysosomes, we immunostained
infectedmacrophagesforgalectin8.Galectin8isacytosoliclectin
that binds galactosides normally located on the interior surface of
FIG4 SLO impairs acidiﬁcation of GAS-containing phagolysosomes. (A) Confocal microscopy images demonstrating the association between the acidotropic
probe LysoTracker Red DND-99 (red) and GFP-expressing GAS (green) at 1 and 2 h of infection. Extracellular GAS bacteria are also stained blue (Alexa 660).
Representative images from one experiment are shown. Scale bars  10 m. The percentage of intracellular bacteria of each strain that colocalized with
LysoTrackerisshown.(B)Percentageofheat-killed(HK)orliveGAScolocalizedwithLysoTrackerat1h(whitebars)or2h(graybars)ofinfection.Meanvalues
 the standard errors of at least three independent experiments are shown. Black asterisks indicate values that differ signiﬁcantly from that for strain 854; red
asterisks indicates values that differ signiﬁcantly from that for the slo mutant. *, P  0.05; **, P  0.01.
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pose these galactosides to the cytosol, thereby promoting galectin
8 binding to the damaged vacuole (37). As a negative control, we
used macrophages containing heat-killed wild-type bacteria that
are expected not to damage the phagolysosome. As expected,
compartments containing heat-killed GAS did not associate with
galectin 8. Similar negative results were obtained with cells in-
fected with live organisms of the slo mutant strain, consistent
with the location of these bacteria in intact, fully acidiﬁed
phagolysosomes(Fig.5).Incontrast,morethan50%oftheintra-
cellular wild-type GAS bacteria were associated with galectin 8 by
1 h of infection. These data support a model in which SLO pores
damage the phagolysosomal membrane, thereby disabling
phagolysosome acidiﬁcation (Fig. 6). We observed an intermedi-
ate level of galectin 8 binding to phagolysosomes containing the
nga(G330D) mutant, which produces SLO and enzymatically in-
active NADase (28% at 1 h, 18% at 2 h). This result implies that
NADase contributes to SLO-mediated injury to the phagosomal
membrane by inhibiting cellular repair mechanisms. Phagolyso-
somes containing the slo(Y255A) mutant accumulated slightly,
though not signiﬁcantly, greater amounts of galectin 8 than those
containing the slo mutant. The fact that infection with the
FIG5 SLOmediatesmembranedamagetoGAS-containingphagolysosomes.(A)ConfocalmicroscopyimagesoftheassociationbetweenGAS(Alexa568,red)
andgalectin8(Alexa488,green)duringtheinfectionofmacrophages.ExtracellularGASbacteriaarebothredandblue(Alexa568and660,respectively).Images
representativeofoneexperimentareshown.Scalebars10m.Thepercentageofintracellularbacteriaofeachstrainassociatedwithgalectin8isindicated.(B)
Percentage of colocalization of GAS and galectin 8 after 1 h (white bars) or 2 h (gray bars) of infection. Mean values  the standard errors of at least three
independent experiments are shown. Black asterisks indicate values that differ signiﬁcantly from that of strain 854, and red asterisks indicate values that differ
signiﬁcantly from that of the slo mutant strain. *, P  0.05; **, P  0.01; ***, P  0.001. HK, heat killed.
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minimal effects on galectin 8 binding implies that damage to the
vacuolar membrane caused by insertion of the SLO(Y255A) pre-
pore complex is sufﬁcient to at least partially disrupt the proton
gradient but insufﬁcient to expose inner membrane galactosides
to the cytosol. Together, these results implicate NADase as con-
tributing to SLO-mediated cytotoxicity by interfering with the
cellular repair of SLO-mediated membrane damage and possibly
by inhibiting the vacuolar proton-ATPase.
Delivery of NADase to the macrophage cytosol depends on
SLO-mediated translocation rather than passive diffusion
through SLO pores. NADase intoxication of epithelial cells is
thoughttooccurbySLO-mediatedtranslocationofNADasefrom
the extracellular space across the cell membrane (22, 23). In con-
trast, in macrophages, SLO-mediated cytotoxicity depends on in-
ternalizationofthebacteria,anobservationthatindicatesthatthe
source of NADase intoxication of macrophages is intracellular
bacteriacontainedwithinphagosomes(16).Accordingly,wewere
interested in determining whether delivery of NADase from GAS
contained within phagosomes occurs by speciﬁc SLO-mediated
translocation or by simple diffusion through SLO pores in the
phagosomal membrane. To distinguish between these possibili-
ties,weconstructedamutantofstrain854thatexpressesNADase
harboring a 10-amino-acid (aa) deletion in the N-terminal do-
main that is required for SLO-mediated translocation (38). The
nga44-53 mutant strain secreted the same amounts of NADase
activityaswild-type854(seeFig.S1inthesupplementalmaterial).
However, the mutant was impaired both in induction of macro-
phage cytotoxicity and in intracellular survival to a degree similar
to that of mutants lacking enzymatically active NADase (Fig. 1F
and 2). These results imply that delivery of NADase from the
phagosome depends on SLO-mediated translocation rather than
simple diffusion through SLO pores in the vacuolar membrane.
DISCUSSION
Macrophages constitute an important element of innate immu-
nitytobacterialinfections,includingthoseduetoGAS.Byphago-
cytosing bacteria, these cells limit bacterial proliferation, and
upon activation, they secrete inﬂammatory cytokines that recruit
and activate other effector cells, including neutrophils. The suc-
cess of GAS as a pathogen depends in part on its ability to evade
capture and killing by macrophages. Production of the secreted
CDC SLO is strongly associated with the capacity of GAS to inca-
pacitate macrophage function: SLO-producing GAS bacteria in-
duce apoptosis of murine and human macrophages in vitro and
resist macrophage-mediated bacterial killing, in contrast to iso-
genic SLO-deﬁcient mutants (16, 18). We now ﬁnd that SLO se-
creted by phagocytosed bacteria damages GAS-containing
phagolysosomes. In addition, SLO mediates the translocation of
the cotoxin NADase into the macrophage cytosol. Both toxins
contributetoGAS-inducedmacrophagecytotoxicityandenhance
GAS survival.
InhumanepithelialkeratinocytesexposedtoGASinvitro,SLO
and NADase production is associated with increased GAS intra-
cellular survival (25, 34). Both toxins prevent maturation of the
GAS-containing vacuole to a functional bactericidal compart-
ment by inhibiting fusion with lysosomes (25, 34, 35). We antici-
pated that enhanced survival of SLO- and NADase-producing
GAS in macrophages would reﬂect a similar mechanism. Unex-
pectedly, we found that phagosomes containing wild-type GAS
followedthesamematurationpathwayasphagosomescontaining
SLO- or NADase-deﬁcient mutants, readily fusing with LAMP-1-
positive lysosomes. Hertzén et al. also found that GAS could sur-
vive in human macrophages (9). In contrast to our results, their
studyfoundthatGASexpressionoftheM1proteinwasassociated
with failure of the GAS-containing phagosome to fuse with lyso-
somes. Possible reasons for the discrepancy in GAS intracellular
trafﬁckingbetweenthatstudyandourscouldbedifferencesinthe
GASstrainsused,themacrophages,ortheirpreparationordiffer-
entexperimentalmethodologies.Inourstudies,phagosomescon-
taining wild-type GAS fused with lysosomes; however, SLO ap-
peared to be highly effective in preventing phagolysosomal
acidiﬁcation, as assessed by localization of the acidotropic probe
LysoTracker. Whereas heat-killed GAS or live SLO-deﬁcient bac-
FIG 6 Model of GAS survival in macrophages. GAS is internalized by phagocytosis. The GAS-containing phagosome fuses with lysosomes to form a
phagolysosome. SLO and NADase are secreted by GAS into this compartment. SLO damages the phagolysosome membrane, preventing phagolysosome
acidiﬁcation.NADaseistranslocatedbySLOfromthephagolysosomeintothemacrophagecytosol,whereitdepletesNADandATP,therebyinhibitingcellular
repair of SLO-mediated membrane damage. The combined action of SLO and NADase interferes with phagolysosomal killing and promotes GAS intracellular
survival.
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acidic pH associated with mature phagolysosomes, phagolyso-
somes containing wild-type GAS failed to acidify. Furthermore,
this SLO-associated inhibition of phagolysosomal acidiﬁcation
didnotrequirecompleteporeformation,asweobservedfailureof
acidiﬁcation in macrophages infected with a strain expressing
SLO(Y255A),amutantproteinthatoligomerizesandinsertsitself
into cholesterol-containing membranes but does not form pores,
lyse erythrocytes, or produce overt cytotoxicity. The sublytic
membrane disruption caused by SLO(Y255A) was sufﬁcient to
defeat phagolysosomal acidiﬁcation.
Production of SLO prevented phagolysosomal acidiﬁcation
but was insufﬁcient to support maximal GAS survival in the ab-
sence of enzymatically active NADase. Experiments with galectin
8 binding to evaluate damage to GAS-containing vacuoles re-
vealed that maximal damage occurred in phagolysosomes that
contained wild-type GAS. Damage was reduced in cells infected
withGASthatproducedwild-typeSLObutenzymaticallyinactive
NADase and was minimal in cells infected with SLO-deﬁcient
GAS or with GAS producing SLO(Y255A). The fact that NADase
production was associated with increased phagolysosomal mem-
brane damage is compatible with previous observations that NA-
Dase depletes intracellular NAD and ATP in epithelial cells ex-
posed to GAS (26). Such depletion of cellular energy stores is
predicted to inhibit cellular repair of SLO pores in the phagolyso-
somal membrane. The contribution of NADase to phagolyso-
somal membrane damage correlates with GAS survival: optimal
survivalwasobservedonlyinGASproducingbothwild-typeSLO
and enzymatically active NADase.
TheﬁndingthatNADasecontributestoGASevasionofkilling
bymacrophagesraisedthequestionofhowNADaseisdeliveredto
the macrophage cytosol during the bacterium-macrophage en-
counter. NADase intoxication of epithelial cells is thought to re-
ﬂect binding of GAS to the cell surface, secretion of NADase and
SLO, association of the two toxins on the cell membrane, and
SLO-mediated translocation of NADase into the host cell. The
situation is quite different for macrophages: GAS bacteria are ef-
ﬁcientlyphagocytosed,andSLOandNADasearesecretedintothe
GAS-containing phagosome. Because SLO damages the phagoly-
sosomalmembrane,itseemedpossiblethatNADasecoulddiffuse
passively through SLO pores into the macrophage cytosol. How-
ever, GAS bacteria that produced enzymatically active NADase
withanN-terminaldeletionthatpreventsSLO-mediatedtranslo-
cationweredefectiveinintracellularsurvival,aresultthatimplies
thatactiveSLO-mediatedtranslocationisrequiredtodeliverNA-
Dase from the phagosome into the cytosol.
These results support a model of GAS evasion of macrophage
killing that depends on both SLO and its cotoxin NADase. While
SLO and NADase have been shown to enhance GAS intracellular
survivalinepithelialcells,thepresentdataidentifyimportantdif-
ferences in the mechanisms through which the toxins modulate
GASsurvivalinmacrophages.Inparticular,NADaseintoxication
of macrophages appears to occur predominantly or exclusively
fromintracellularGAScontainedwithinphagosomesorphagoly-
sosomes. SLO secreted by GAS within these compartments does
not prevent the fusion of GAS-containing vacuoles with lyso-
somes, as occurs in keratinocytes. However, SLO damages the
phagolysosomal membrane and interferes with the development
ormaintenanceofanacidicintraluminalpH.Despitethepresence
of SLO-mediated damage to the phagolysosomal membrane,
translocation of NADase into the macrophage cytosol does not
occur by passive diffusion but requires SLO-mediated transloca-
tion. We conclude that the coordinated action of SLO and NA-
Dase disables macrophage bactericidal mechanisms and mediates
GAS evasion of this key effector of host innate immunity. The
ability of GAS to escape macrophage killing favors persistence of
the organism in colonization of the human pharynx and may be
particularly important in invasive infection where clinical isolates
often harbor spontaneous inactivating mutations in the CsrRS or
RopB (Rgg) regulatory system, resulting in marked upregulation
of both SLO and NADase (39–41).
MATERIALS AND METHODS
Bacterialstrains,macrophagecellline,andgrowthconditions.TheGAS
strainsusedinthisstudyarelistedinTable1.GAS854isanMtype1strain
isolated from a patient with a retroperitoneal abscess (42). GAS strains
weregrowninTodd-Hewittbroth(Difco)supplementedwith0.5%yeast
extract (THY) at 37°C without shaking or on THY agar supplemented
with 5% deﬁbrinated sheep blood (BD Biosciences). For cloning experi-
ments, Escherichia coli strain DH5 was grown in Luria-Bertani broth
(Difco)at37°C.Whenrequired,antibioticswereaddedtothemediumat
thefollowingconcentrations:forE.coli,erythromycinat100g/ml,spec-
tinomycinat100g/ml,andcarbenicillinat100g/ml;forGAS,penicil-
lin at 20 g/ml, gentamicin at 200 g/ml, spectinomycin at 100 g/ml,
anderythromycinat1g/ml.THP-1humanmonocyte-macrophagecells
TABLE 1 Bacterial strains used in this study
Strain Genotype/relevant properties Reference
854 Wild-type, M type 1, invasive clinical isolate 45
854 nga nga deletion mutant This study
854 nga(G330D) G330D point mutant of NADase, lacks NADase activity This study
854 slo slo deletion mutant This study
854 slo(Y255A) SLO Y255A point mutant that lacks SLO pore formation but retains NADase translocation This study
854 slo(Y255A) nga(G330D) Double point mutant that lacks SLO pore formation and NADase activity This study
854 nga44-53 Deletion of 10-aa region of NADase translocation domain that preserves enzymatic activity
but prevents NADase translocation
This study
854/phasp-gfp 854 expressing GFP from plasmid phasp-gfp, Spcra This study
854 nga/phasp-gfp 854 nga mutant expressing GFP from plasmid phasp-gfp, Spcr This study
854 nga(G330D)/phasp-gfp 854 nga(G330D) mutant expressing GFP from plasmid phasp-gfp, Spcr This study
854 slo/phasp-gfp 854 slo mutant expressing GFP from plasmid phasp-gfp, Spcr This study
854 slo(Y255A)/phasp-gfp 854 slo(Y255A) mutant expressing GFP from plasmid phasp-gfp, Spcr This study
854 slo(Y255A) nga(G330D)/phasp-gfp 854 slo(Y255A) nga(G330D) double mutant expressing GFP from plasmid phasp-gfp, Spcr This study
a Spcr, spectinomycin resistance.
Bastiat-Sempe et al.
8
® mbio.asm.org September/October 2014 Volume 5 Issue 5 e01690-14were purchased from the American Type Culture Collection. Monocytes
were cultured in RPMI medium (Life Technologies) supplemented with
10%heat-inactivatedfetalbovineserum(FBS;LifeTechnologies)at37°C
in 5% CO2.
Reagents. Restriction enzymes were purchased from Thermo Scien-
tiﬁc, and cell culture reagents were from Life Technologies. Unless other-
wisespeciﬁed,reagentswerepurchasedfromSigma-Aldrich.Phorbol12-
myristate 13-acetate (PMA) was diluted in dimethyl sulfoxide and stored
at 20°C (16). The primary antibodies (rabbit anti-GAS group A carbo-
hydrateantibodyconjugatedtoAlexaFluor660,488,or568;mouseanti-
LAMP-1 antibody; anti-galectin 8 afﬁnity-puriﬁed goat polyclonal IgG)
and secondary antibodies (conjugated to Alexa Fluor 488 or 568) used
were previously described (25, 35). LysoTracker Red DND-99 was pur-
chased from Molecular Probes/Life Technologies and freshly diluted in
RPMI medium containing 10% FBS prior to use.
DNAmanipulations.TogeneratetheG330DsubstitutioninNADase
and the Y255A substitution in SLO, GAS strain 854 was transformed by
electroporation with plasmids pJRS233-ngaG330D and pJRS233-
sloY255A, respectively (25). Transformants were then subjected to allelic
exchange to replace the wild-type gene with the mutated allele as previ-
ously described (43). Plasmids pnga (22) and pJRS233-ngaG330D, re-
spectively, were used to delete nga from 854 and to introduce the
nga(G330D) mutation into the slo(Y255A) mutant to create the
slo(Y255A) nga(G330D) double mutant. The slo mutant was generated
in a previous study (16).
ToconstructtheNADasetranslocationnga44-53mutant,aplasmid
expressing ifs and nga carrying a deletion of 30 bp, from position 129 to
position 159, was synthesized by Genewiz, Inc. This mutation introduces
a deletion of amino acids 44 to 53 into the N-terminal translocation do-
main of NADase. Oligonucleotide primers BBS97 and BBS4 (GGATCCG
TGTTTACAAACCAATGGATG and GTCGACCCCTGATGGACCTCT
GTTACC, respectively) were used to amplify the nga DNA fragment
carrying the deletion. The resulting 1-kb fragment was subsequently di-
gested with BamHI and SalI and ligated into pJRS233. The newly formed
pJRS233-nga44-53 plasmid was then transformed into strain 854.
Transformants were then subjected to allelic gene replacement (43).
Cytotoxicity and survival assays. Macrophage cytotoxicity was as-
sessed by LDH release measurements. THP-1 cells were seeded into 24-
well plates and differentiated into macrophages with PMA as previously
described (16). Infections were performed as previously described, with
the following modiﬁcations (16). GAS bacteria were grown in THY to an
A600 of 0.3 to 0.4, collected by centrifugation, washed with phosphate-
buffered saline (PBS), and resuspended and diluted in RPMI medium
with 10% FBS. Macrophages were washed once and infected with GAS at
amultiplicityofinfection(MOI)of4.After90minofinfection,penicillin
and gentamicin were added to the medium and kept throughout the ex-
perimenttokillextracellularbacteria.Thirtyminutes(T0),2h(T2),or4h
(T4) later, supernatants were collected for LDH measurements with a
cytotoxicitykitfromRoche.Uninfectedcellslysedwith10%TritonX-100
were used as a standard of complete cell lysis.
Bacterial survival assays were performed as previously described (16).
Brieﬂy, macrophages were infected with GAS for 90 min. After infection,
extracellular bacteria were killed by the addition of antibiotics to the me-
dium. Macrophages were then washed and returned to antibiotic-free
mediumfor2or4h.Todeterminethepercentageofsurvival,bacteriathat
survivedintracellularlyandbacteriathatescapedfrommacrophageswere
quantiﬁed by quantitative culture of macrophage lysates and cell culture
medium. Survival was calculated as follows: (CFU recovered at 2 or 4 h/
CFU recovered at time zero)  100%.
Immunoﬂuorescence.THP-1monocyteswereseededontocoverslips
in 24-well plates at 1  106/ml in RPMI medium with 10% FBS in the
presenceof25nMPMAtoinducetheirdifferentiationintomacrophages.
After a 24-h incubation at 37°C in 5% CO2, cells were washed three times
withPBSandthenincubatedinfreshRPMImediumcontaining10%FBS
for an additional 24 h prior to infection. GAS strains were grown in THY
until the early exponential phase (A600, ~0.25), collected by centrifuga-
tion, washed once in PBS, and resuspended in 1 ml of RPMI medium
supplemented with 10% FBS prior to infection. Macrophages were in-
fectedataMOIof10for1h.Afterinfection,sampleswerewashedinPBS
and extracellular bacteria were stained with Alexa Fluor 660-conjugated
anti-groupAcarbohydrateantibodyfor15min.Samplesweretheneither
immediately subjected to the immunostaining protocol described below
or treated ﬁrst with an antibiotic mixture (penicillin at 20 g/ml and
gentamicinat200g/ml)tokillextracellularbacteria,washedthreetimes
with PBS, and incubated for an additional hour postinfection at 37°C in
5% CO2 before immunostaining. Unless otherwise speciﬁed, all of the
followingstepswereperformedinthedarkatroomtemperature.Infected
cells were ﬁxed with 2% paraformaldehyde (PFA) in PBS (pH 7.4) for
30 min. Cells were then washed three times with PBS, permeabilized for
15 min with 0.1% Triton X-100 in PBS, washed again three times in PBS,
and blocked for 30 min in PBS containing 0.5% bovine serum albumin
(BSA). Cells were then incubated for 1 h with the primary (mouse anti-
LAMP-1 or goat anti-galectin 8) antibody diluted in 0.5% BSA in PBS.
After three washes in PBS, cells were incubated for 1 h with Alexa Fluor
488-or568-conjugatedrabbitanti-GASgroupAcarbohydrateandeither
goat anti-mouse Alexa Fluor 568-conjugated IgG or donkey anti-goat
Alexa Fluor 488-conjugated IgG. Slides were mounted in ProLong Gold
medium (Molecular Probes) and incubated for 16 to 24 h at room tem-
perature in the dark before imaging.
LysoTrackerRedlabeling.Cellswereinfectedasdescribedabovewith
GAS transformed with plasmid phasp-gfp, which encodes green ﬂuores-
centprotein(GFP),aspreviouslydescribed(35,44).Cellswereincubated
with 50 nM LysoTracker Red DND-99 freshly diluted in RPMI medium
plus 10% FBS for 5 to 10 min after either 1 or2ho finfection. Cells were
then washed and ﬁxed with 2% PFA. Coverslips were then immediately
mounted in Prolong gold medium and incubated for 16 to 24 h at room
temperature in the dark before confocal imaging.
Confocal microscopy. Confocal microscopy was performed at the
Harvard Digestive Diseases Center core facility as previously described
(25,35).ImageacquisitionandanalysiswereperformedwithSlidebook5
(Intelligent Imaging Innovations, Denver, CO). To quantify the percent-
age of GAS colocalization with cell markers, three to ﬁve independent
experiments were performed and at least 300 intracellular bacteria were
counted for each experiment.
Statisticalanalysis.Dataareexpressedasmeanvaluesthestandard
errors of the means. The statistical signiﬁcance of differences between
groupswasevaluatedbytwo-tailedStudentttestwithGraphPadPrism.A
P value of 0.05 was considered statistically signiﬁcant.
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